Company Valuation: SaintMed

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025
Market Cap 1 3,039 1,921 1,544 955.4 494.3
Change - -36.78% -19.64% -38.11% -48.26%
Enterprise Value (EV) 1 2,825 1,429 1,255 988.6 774.7
Change - -49.43% -12.16% -21.23% -21.63%
P/E 8.4x 6.48x 20.3x 23x 46.6x
PBR 3.38x 1.87x 1.72x 1.26x 0.69x
PEG 0x -0.4x -0.3x -0.5x -0.6x
Capitalization / Revenue 1.87x 0.96x 1.87x 1.2x 0.54x
EV / Revenue 1.74x 0.71x 1.52x 1.25x 0.85x
EV / EBITDA 6.49x 3.59x 11.1x 11.8x 10.9x
EV / EBIT 6.83x 3.82x 13.9x 17.3x 20.7x
EV / FCF 39.9x 3.52x 196x -9.06x -7.26x
FCF Yield 2.51% 28.4% 0.51% -11% -13.8%
Dividend per Share 2 0.4762 0.75 0.3 0.75 0.06
Rate of return 3.52% 8.77% 4.17% 16.3% 2.52%
EPS 2 1.61 1.32 0.3539 0.2 0.0511
Distribution rate 29.6% 56.8% 84.8% 375% 117%
Net sales 1 1,621 2,010 827.3 793.2 910.2
EBITDA 1 435.5 397.5 113.3 83.68 71.05
EBIT 1 413.8 373.8 90.01 57.02 37.35
Net income 1 319.8 296.7 79.24 41.68 10.62
Net Debt 1 -213.3 -492.2 -288.8 33.12 280.4
Reference price 2 13.524 8.550 7.200 4.600 2.380
Nbr of stocks (in thousands) 224,700 224,684 214,423 207,703 207,703
Announcement Date 28/02/22 27/02/23 29/02/24 28/02/25 03/03/26
1THB in Million2THB
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
32.73x4.4x16.91x2.25% 197B
20.72x3.58x12.64x3.23% 118B
17.95x0.21x13.08x0.73% 62.55B
30.43x7.56x19.31x1.31% 52.4B
36.65x3.51x12.03x2.06% 51.81B
35.66x6.27x19.69x-.--% 33.57B
45.39x1.29x11.79x0.17% 30.34B
40.81x7.15x25.65x0.26% 24.63B
19.87x3.06x11.18x1.44% 23.81B
Average 31.13x 4.11x 15.81x 1.27% 66.04B
Weighted average by Cap. 29.56x 4.01x 15.48x 1.84%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA